Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration Resistant Prostate Cancer × AGN 194204 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 1 Lung Neoplasms 1 Castration Resistant Prostate Cancer 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

bintrafusp alfa protein, human 1 Triamcinolone Acetonide 1 TH 302 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Injections, Intramuscular 1 ALT-803 1 AGN 194204 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01540071 2021-05-14

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Io Therapeutics

Phase 2 Completed

38 enrolled 11 charts

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡